Blood Pressure Monitoring After Hydralazine Administration

Pharmacokinetics and Monitoring Timeline

• Hydralazine is a direct-acting vasodilator that begins to lower blood pressure within 10-30 minutes of administration, with the hypotensive effect typically lasting 2-4 hours, requiring monitoring throughout this period 1, 2
• The hypotensive effect typically lasts 2-4 hours, requiring monitoring throughout this period 2

Monitoring Protocol for Different Routes of Administration

Intravenous Administration

• For IV hydralazine, blood pressure should be checked within 10-30 minutes of administration, and continue monitoring every 15-30 minutes for the first hour, then hourly for 2-4 hours 2

Special Considerations

• Hydralazine can cause reflex tachycardia, so heart rate should be monitored alongside blood pressure 3
• For patients with low baseline diastolic pressure, more frequent monitoring is recommended due to risk of hypotension 3

Potential Adverse Effects Requiring Monitoring

• Reflex tachycardia may occur as a compensatory response 3
• Sodium and water retention may counteract the antihypertensive effect over time 2
• Monitor for symptoms of hypotension: dizziness, lightheadedness, or syncope 3

Monitoring Recommendations Based on Clinical Setting

• For hypertensive urgency: Check blood pressure at 10-30 minutes, 1 hour, and 2-4 hours post-administration 2
• For heart failure patients receiving hydralazine with isosorbide dinitrate: The American College of Cardiology recommends monitoring blood pressure after initiation and during dose titration 4